" /> Neoantigen srRNA Vaccine JCXH-212 - CISMeF





Preferred Label : Neoantigen srRNA Vaccine JCXH-212;

NCIt synonyms : Vaccine JCXH-212;

NCIt definition : A cancer vaccine consisting of self-replicating RNA (srRNA) encoding a patient's tumor-specific neoantigens, with potential immunomodulatory and antineoplastic activities. Upon administration of neoantigen srRNA vaccine JCXH-212, the srRNA is taken up by and translated into the neoantigens in the patient's antigen-presenting cells (APCs), primarily dendritic cells (DCs), and presented by major histocompatibility complex (MHC) molecules on the surface of the APCs. This may activate tumor antigen-specific T-cells to kill cancer cells expressing these neoantigens.;

Molecule name : JCXH 212; JCXH-212;

NCI Metathesaurus CUI : CL1912846;

Details


You can consult :


Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.